326 related articles for article (PubMed ID: 4064843)
101. Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model.
Borbath I; Grégoire V; Bergström M; Laryea D; Långström B; Pauwels S
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):19-27. PubMed ID: 11807603
[TBL] [Abstract][Full Text] [Related]
102. Phorbol ester enhances deoxynucleoside incorporation while inhibiting proliferation of K-562 cells.
Colamonici OR; Trepel JB; Neckers LM
Cytometry; 1985 Nov; 6(6):591-6. PubMed ID: 2415311
[TBL] [Abstract][Full Text] [Related]
103. Validation of bromodeoxyuridine immunohistochemistry for localization of S-phase cells in decalcified tissues. A comparative study with tritiated thymidine autoradiography.
Apte SS
Histochem J; 1990 Aug; 22(8):401-8. PubMed ID: 2228729
[TBL] [Abstract][Full Text] [Related]
104. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.
Nagashima T; Hoshino T
Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331
[TBL] [Abstract][Full Text] [Related]
105. 3H-thymidine autoradiography and cytophotometric analysis of needle aspirates from human tumours during radiation therapy, endocrine therapy and chemotherapy.
Klintenberg C; Bjelkenkrantz K; Månsson JC; Killander D; Nordenskjöld B
Acta Radiol Oncol; 1985; 24(2):117-22. PubMed ID: 2988272
[TBL] [Abstract][Full Text] [Related]
106. Optimal conditions for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.
Browman GP; Kanclerz A; Booker L; Daya D; Archibald SD; Young JE; Goldsmith CH
Cell Prolif; 1991 Nov; 24(6):579-85. PubMed ID: 1764538
[TBL] [Abstract][Full Text] [Related]
107. Mathematical model analysis of mouse epidermal cell kinetics measured by bivariate DNA/anti-bromodeoxyuridine flow cytometry and continuous [3H]-thymidine labelling.
Aarnaes E; Kirkhus B; Clausen OP
Cell Tissue Kinet; 1990 Sep; 23(5):409-24. PubMed ID: 2245440
[TBL] [Abstract][Full Text] [Related]
108. [Several parameters of the kinetics of cellular proliferation in human macroglial tumors].
Kotel'nikov VM; Arkhangel'skiĭ VV; Safronov VA
Vopr Neirokhir; 1976; (1):36-41. PubMed ID: 1258445
[TBL] [Abstract][Full Text] [Related]
109. [Proliferative characteristics of the cells].
Nakamura S
Rinsho Byori; 1990 Nov; Suppl 87():111-25. PubMed ID: 2287082
[No Abstract] [Full Text] [Related]
110. Mixed lymphocyte reactions evaluated by means of bromodeoxyuridine incorporation.
Bontadini A; Conte R; Dinota A; Belletti D; Tassi C; Tazzari PL; Gobbi M
Haematologica; 1990; 75(1):7-11. PubMed ID: 2140106
[TBL] [Abstract][Full Text] [Related]
111. Improved methods for the determination of 5-bromo-2-deoxyuridine labelling index in clones and colonies growing in plasma clots.
Di Nucci GD; Tazzari PL; Bontadini A; Tassi C; Dinota A; Pileri S; Gobbi M
Basic Appl Histochem; 1990; 34(1):71-7. PubMed ID: 2337406
[TBL] [Abstract][Full Text] [Related]
112. The use of flow cytometry and cell sorting in a human colon carcinoma model.
Noguchi PD; Cunningham RE; Ridge J; Muller J
Cytometry; 1985 May; 6(3):254-9. PubMed ID: 3996140
[TBL] [Abstract][Full Text] [Related]
113. Fluorescence enhancement of DNA-bound TO-PRO-3 by incorporation of bromodeoxyuridine to monitor cell cycle kinetics.
Beisker W; Weller-Mewe EM; Nüsse M
Cytometry; 1999 Nov; 37(3):221-9. PubMed ID: 10520203
[TBL] [Abstract][Full Text] [Related]
114. Combined flow and absorption DNA measurements of [3H]TdR-labelled tumour cells. I. Studies of MCa-11 cells grown as tumours in vivo and as exponential cultures in vitro.
Allison DC; Chakerian M; Ridolpho PF; Anderson S; Curley S; Wilder ME; Robertson J
Cell Tissue Kinet; 1987 May; 20(3):273-90. PubMed ID: 3690623
[TBL] [Abstract][Full Text] [Related]
115. Cell cycle analysis of synchronized Chinese hamster cells using bromodeoxyuridine labeling and flow cytometry.
Bussink J; Terry NH; Brock WA
In Vitro Cell Dev Biol Anim; 1995; 31(7):547-52. PubMed ID: 8528504
[TBL] [Abstract][Full Text] [Related]
116. A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
Wijsman JH; Cornelisse CJ; Keijzer R; van de Velde CJ; van Dierendonck JH
Br J Cancer; 1991 Sep; 64(3):463-8. PubMed ID: 1911185
[TBL] [Abstract][Full Text] [Related]
117. Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry.
Le Pessot F; Michel P; Paresy M; Lemoine F; Hellot MF; Paillot B; Scotte M; Peillon C; Hemet J
Pathol Res Pract; 2001; 197(6):411-8. PubMed ID: 11432668
[TBL] [Abstract][Full Text] [Related]
118. Immunocytochemical labeling of S-phase cells of human tumors by monoclonal antibodies in vitro.
Hu YQ; Barrows GH
Chin Med J (Engl); 1988 Apr; 101(4):263-6. PubMed ID: 3138085
[No Abstract] [Full Text] [Related]
119. High-resolution detection of newly synthesized DNA by anti-bromodeoxyuridine antibodies identifies specific chromatin domains.
Mazzotti G; Rizzoli R; Galanzi A; Papa S; Vitale M; Falconi M; Neri LM; Zini N; Maraldi NM
J Histochem Cytochem; 1990 Jan; 38(1):13-22. PubMed ID: 2403578
[TBL] [Abstract][Full Text] [Related]
120. Characterization and cell cycle kinetics of hepatocytes during rat liver regeneration: in vivo BrdUrd incorporation analysed by flow cytometry and electron microscopy.
Vitale M; Rizzoli R; Mazzotti G; Zamai L; Galanzi A; Rizzi E; Manzoli L; Matteucci A; Papa S
Cell Prolif; 1991 May; 24(3):331-8. PubMed ID: 2039808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
